| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 02/08/2006 | EP1623715A1 A composition comprising a pharmacologically active agent coupled to a target cell specific component, and a saponin |
| 02/08/2006 | EP1622646A2 Treatment of lupus targeting the macrophages or the folate receptor |
| 02/08/2006 | EP1622645A2 Compositions and methods for stem cell delivery |
| 02/08/2006 | EP1622628A2 Complex of ras-farnesyltransferase inhibitor, a cyclodextrin, and ethanol |
| 02/08/2006 | EP1622608A2 Compositions and methods for treating cancer |
| 02/08/2006 | EP1622594A2 Homogeneous, thermoreversible alginate films and soft capsules made therefrom |
| 02/08/2006 | EP1622588A2 Delivery systems of homogeneous thermoreversible alginate films |
| 02/08/2006 | EP1622573A2 Molecules enhancing dermal delivery of influenza vaccines |
| 02/08/2006 | EP1622572A2 Conjugates and compositions for cellular delivery |
| 02/08/2006 | EP1622566A2 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof |
| 02/08/2006 | EP1622563A2 Improved heat shock protein-based vaccines and immunotherapies |
| 02/08/2006 | EP1622554A1 Compositions containing a combination of a pharmaceutical agent or a cosmetic agent and an oxy group-bearing aromatic aldehyde |
| 02/08/2006 | EP1622448A2 Nasal administration of the lh-rh analog leuprolide |
| 02/08/2006 | EP1478393A4 Anti-pathogen treatements |
| 02/08/2006 | EP1453517B1 Platinum derivative pharmaceutical formulations |
| 02/08/2006 | EP1337262A4 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 02/08/2006 | EP1331902A4 Improved ophthalmic and contact lens solutions containing forms of vitamin b |
| 02/08/2006 | EP1289642B1 Nanocapsules having a polyelectrolyte envelope |
| 02/08/2006 | EP1216035B1 Preparation containing active ingredients and/or auxiliary agents with a controlled release of these substances and the use and production of the same |
| 02/08/2006 | EP1039933B1 METHODS AND COMPOSITIONS FOR ENHANCING IMMUNE RESPONSE AND FOR THE PRODUCTION OF $i(IN VITRO) MABS |
| 02/08/2006 | EP1025230B1 ANTIBODIES, INCLUDING Fv MOLECULES, AND IMMUNOCONJUGATES HAVING HIGH BINDING AFFINITY FOR MESOTHELIN AND METHODS FOR THEIR USE |
| 02/08/2006 | EP0736041B1 Transparent liquid for encapsulated drug delivery |
| 02/08/2006 | CN1732212A Multi-arm polypeptide-poly (ethylene glycol) block copolymers as drug delivery vehicles |
| 02/08/2006 | CN1732207A Maleamic acid polymer derivatives and their bioconjugates |
| 02/08/2006 | CN1732206A Hydrolytically stable maleimide-terminated polymers |
| 02/08/2006 | CN1732151A 4-nitro-2-[(4'-methoxyl)-phenoxy]-toluenesulfonamide derivant and its medical uses |
| 02/08/2006 | CN1732016A Modified cytokines for use in cancer therapy |
| 02/08/2006 | CN1732008A Use of rimexolone in the treatment of dry eye |
| 02/08/2006 | CN1731988A Sustained release pharmaceutical composition |
| 02/08/2006 | CN1731979A Allergen dosage form |
| 02/08/2006 | CN1731963A Stable topical drug delivery compositions |
| 02/08/2006 | CN1730494A Cobratide modified by polyethylene glycol, its preparation method and uses |
| 02/08/2006 | CN1240438C Particulate vitamin composition |
| 02/08/2006 | CN1240437C Oral administered self-emulsifying formulations of pyranone proteinase inhibitors |
| 02/08/2006 | CN1240392C Agent for promoting cell activation for external use |
| 02/08/2006 | CN1240384C Transdermal administration of huperzine |
| 02/08/2006 | CN1240377C Stable pharmaceutical composition of pravastatin |
| 02/08/2006 | CN1240375C Preparation of low dosage medicinal composition with uniform distribution and effect |
| 02/08/2006 | CN1240374C Rapidly disintegrating methylcellulose tablets |
| 02/08/2006 | CN1240373C Porous drug matrices and methods of manufacture thereof |
| 02/07/2006 | US6995209 Having a continuous aqueous phase comprising a thermally reversible viscosifying polymer, especially a polymer having a polyoxyalkylene block having a hydrophobic region and a hydrophilic region and an optionally substituted acrylic acid |
| 02/07/2006 | US6995189 comprises fatty acids; for treatment/prevention of sepsis or inflammatory shock |
| 02/07/2006 | US6995186 For therapy of allergic or inflammatory disorders of the eye and nose |
| 02/07/2006 | US6995169 Synergistic mixture |
| 02/07/2006 | US6995166 Method and composition for supplementation of nutritional deficiencies in renal patients |
| 02/07/2006 | US6995137 Water-soluble natural film and its preparing method |
| 02/07/2006 | US6995135 Peptides and peptidomimetics having anti-proliferative activity and/or that augment nucleic acid damaging agents or treatments |
| 02/07/2006 | US6994977 Combining a compound to be tested, a host cell expressing a recombinant protein containing a mammalian C-C chemokine receptor 3 and a ligand for binding of ligand to such receptor, detecting the formation of a receptor-ligand complex |
| 02/07/2006 | US6994889 a coating liquid for preperation of a hard coating layer for food or medicine containing any one of sugar/sugar alcohols selected from maltitol, xylitol, erythritol, mannitol, lactitol, trehalose, sucrose, and oxidized starch |
| 02/07/2006 | US6994873 Modified release granules |
| 02/07/2006 | US6994872 Monolayer sugar-coated tablet and process for preparation thereof |
| 02/07/2006 | US6994869 amino acid source, a carbohydrate source, a lipid source, and a fatty acid delivery agent wherein the fatty acid has a bond hydrolysable in the colon to deliver free fatty acids such as short chain fatty acid acetate without having adverse affect |
| 02/07/2006 | US6994863 Pharmaceutical and cosmetic carrier and composition for topical application |
| 02/07/2006 | US6994862 Comprising 9-90% by weight monoglyceride compound, 0.01-90% by weight emulsifier, 0-50% by weight water-insoluble material, 0-90.9% by weight of organic solvent; drug delivery |
| 02/07/2006 | US6994859 Biologically active, hemagglutinin from type A Clostridium botulinum and methods of use |
| 02/07/2006 | US6994857 A Therapeutic protein (e.g., a polypeptide, antibody, or peptide, or fragments and variants) fused to albumin, is sufficient to prolong the shelf-lilfe of therapeutic protein |
| 02/07/2006 | US6994847 Stabilized interferon compositions |
| 02/07/2006 | US6994843 Delivery of stimulants through an inhalation route |
| 02/07/2006 | CA2355779C Improved release of medicament active agents from a chewing gum coating |
| 02/07/2006 | CA2137764C Pharmaceutical compositions comprising solutions or dispersions of a staurosporine active ingredient in a saturated polyalkylene glycol glyceride |
| 02/07/2006 | CA2135639C Controlled release preparation containing a salt of morphine |
| 02/07/2006 | CA2026147C Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 02/02/2006 | WO2006012264A1 Compounds of the inventions of guanylyl cyclase c |
| 02/02/2006 | WO2006012145A1 Phospholipid gel compositions for drug delivery and methods of treating conditions using same |
| 02/02/2006 | WO2006011915A1 Methods and compositions for the treatment of pain and other alpha 2 adrenergic-mediated conditions |
| 02/02/2006 | WO2006011637A1 Film-coated tablet |
| 02/02/2006 | WO2006011044A1 Amorphous cyclodextrin compositions |
| 02/02/2006 | WO2006010939A1 Composition for delivery of an active agent |
| 02/02/2006 | WO2006010394A2 Medicament in a multilayer form |
| 02/02/2006 | WO2006010360A2 Carrier for medicaments for obtaining oral bioavailability |
| 02/02/2006 | WO2005117977A3 Tissue-specific imaging and therapeutic agents targeting proteins expressed on lung endothelial cell surface |
| 02/02/2006 | WO2005105059B1 Permeation enhancer comprising genus curcuma or germacrone for transdermal and topical administration of active agents |
| 02/02/2006 | WO2005099752A3 Antigen delivery vectors and constructs |
| 02/02/2006 | WO2005097203A3 Serum protein conjugates of ion channel modulating compounds and uses thereof |
| 02/02/2006 | WO2005068639A3 Particle-induced ghrelin immune response |
| 02/02/2006 | WO2005032594A3 Alkylators linked to polyamides as dna binding agents |
| 02/02/2006 | WO2005004809A3 Multivalent carriers of bi-specific antibodies |
| 02/02/2006 | WO2005001038A3 Recombinant anti-cd30 antibodies and uses thereof |
| 02/02/2006 | US20060026700 Tissue specific genes and gene clusters |
| 02/02/2006 | US20060025584 Crystallization of polyol compositions, crystalline polyol composition product and use thereof |
| 02/02/2006 | US20060025573 Reducing the immunogenicity of fusion proteins |
| 02/02/2006 | US20060025524 Novel hydrogels and uses thereof |
| 02/02/2006 | US20060025380 Formulations for non-parenteral use including hydrophobic cyclodextrins |
| 02/02/2006 | US20060025330 Electrostatic bonding type macromolecular micelle drug carrier and drug carried thereon |
| 02/02/2006 | US20060025326 Method for treating carrier particles and its use |
| 02/02/2006 | US20060024832 Water-soluble derivatives of lipophilic drugs |
| 02/02/2006 | US20060024828 Process of making a compound by forming a polymer from a template drug |
| 02/02/2006 | US20060024804 Isoforms isolated and purified from mammalian colostrum |
| 02/02/2006 | US20060024795 Interferon-Like molecules and uses thereof |
| 02/02/2006 | US20060024730 TF binding compounds |
| 02/02/2006 | US20060024379 Protein microspheres having injectable properties at high concentrations |
| 02/02/2006 | US20060024371 Crosslinking a protein with derivative of a hydrophilic polymer with a functionality of at least three to form a non-liquid hydrogel and incorporating a therapeutic agent; the hydrogel degrades over time back to a liquid form |
| 02/02/2006 | US20060024352 Phytosterol nutritional supplements |
| 02/02/2006 | US20060024351 Hydrating breath freshening beverage compositions and method therefor |
| 02/02/2006 | US20060024336 Ion binding compositions |
| 02/02/2006 | US20060024290 prophylactic and/or therapeutic agent for the modification of fertility and behaviour patterns of animals, the achievement of livestock production gains such as increasing growth, decreasing feed conversion ratios or the control of unwanted organoleptic characteristics |
| 02/02/2006 | US20060024283 Red blood cells loaded with S-nitrosothiol and uses therefor |
| 02/02/2006 | US20060024267 TNFr/OPG-like molecules and uses thereof |
| 02/02/2006 | US20060024265 Administering sodium-binding polymer of a core-shell, having an in vivo sodium binding capacity of 4 mmol or more per gram of polymer for removing sodium in gastro-intestinal tract ; treatment of hypertension, chronic heart failure, end stage renal disease, liver cirrhosis, fluid overload |
| 02/02/2006 | US20060024242 Solubilizing liquid of refractory element and producing method thereof |